Gynecologic Oncology Articles

Expert Discusses Role of Vaginal Microbes in Endometrial Cancer Detection
A direct assessment of the uterine microbiome in patients with endometrial cancer has revealed a potential predictive role for vaginal microbes.
Early Endometrial Cancer Mutations Detectable in Uterine Lavage Fluid
As mortality rates continue to climb in endometrial cancer, there remains a pressing need for effective screening and diagnostics.
CT-Planned, High-Dose-Rate Brachytherapy Effective in Cervical Cancer
The use of CT-planned high-dose-rate intracavitary brachytherapy demonstrated excellent local control and survival for patients with stage I/II cervical carcinoma, according to the results of a recent study published in Gynecologic Oncology.
Expedited Surgery Increases Mortality Risk in Endometrial Cancer
Patients with endometrial cancer who receive surgery in the first 2 weeks after diagnosis have worse survival outcomes, according to a study recently reported in the American Journal of Obstetrics and Gynecology.
Study Links NSAIDs to Increased Mortality in Endometrial Cancer
An association was found between the use of nonsteroidal anti-inflammatory drugs and endometrial cancer risk.
Levine Sheds Light on Precision Medicine in Gynecologic Malignancies
Significant progress is being made in the treatment of gynecologic malignancies, especially in ovarian cancer, according to Douglas A. Levine, MD.
Birrer Assesses Current Challenges in Cervical Cancer
Oncologists continue to face several challenges when it comes to the prevention and treatment of cervical cancer, according to Michael Birrer, MD, PhD.
HPV-Vaccinated Patients Require Less Frequent Cervical Cancer Screening
Women who have been vaccinated against HPV can undergo less-intensive cervical cancer screening than is currently recommended, according to new findings released from the Harvard T.H. Chan School of Public Health.
More Than Half of Cervical Cancer Patients Not Receiving Recommended Treatment
Results of a new study found that less than half of patients with advanced cervical cancer are receiving all 3 of the therapies considered standard of care for the disease: external beam radiation therapy, brachytherapy, and chemotherapy.
Pembrolizumab Shows Promising Antitumor Activity in Cervical Cancer
Pembrolizumab (Keytruda) was well tolerated and demonstrated promising antitumor activity in patients with PD-L1–positive advanced cervical squamous cell cancer.
Publication Bottom Border
Border Publication